Saikat Ghosh (S Ghosh)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Benign Prostatic Hyperplasia

Positron Emission Tomography

Top Venues

Molecular pharmaceutics

Chemical science

Chemical communications (Cambridge, England)

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

James L Wood, Saikat Ghosh, Zachary H Houston, Nicholas L Fletcher, James Humphries, Karine Mardon, Dewan T Akhter, William Tieu, Alesia Ivashkevich, Michael P Wheatcroft, Kristofer J Thurecht, Rachel Codd
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical science 15 (30) (2024)
James L Wood, Saikat Ghosh, Zachary H Houston, Nicholas L Fletcher, James Humphries, Karine Mardon, Dewan T Akhter, William Tieu, Alesia Ivashkevich, Michael P Wheatcroft, Kristofer J Thurecht, Rachel Codd
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical science 15 (30) (2024)
Saikat Ghosh, Nicholas L Fletcher, Pie Huda, Zachary H Houston, Christopher B Howard, Maria E Lund, Yanling Lu, Douglas H Campbell, Bradley J Walsh, Kristofer J Thurecht
Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics 20 (3) (2023)
Aditya Ardana, Saikat Ghosh, Pie Huda, Nicholas L Fletcher, Kristofer J Thurecht, Charlotte C Williams
RAFT Polymer-Antibody Conjugation: Squaramide Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody with Full Retention of Activity and Increased Tumor Uptake In Vivo . Molecular pharmaceutics (2023)
Saikat Ghosh, Nicholas L Fletcher, Pie Huda, Zachary H Houston, Christopher B Howard, Maria E Lund, Yanling Lu, Douglas H Campbell, Bradley J Walsh, Kristofer J Thurecht
Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics (2023)
Saikat Ghosh, Nicholas L Fletcher, Pie Huda, Zachary H Houston, Christopher B Howard, Maria E Lund, Yanling Lu, Douglas H Campbell, Bradley J Walsh, Kristofer J Thurecht
Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics 20 (3) (2023)
Saikat Ghosh, Nicholas L Fletcher, Pie Huda, Zachary H Houston, Christopher B Howard, Maria E Lund, Yanling Lu, Douglas H Campbell, Bradley J Walsh, Kristofer J Thurecht
Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics 20 (3) (2023)
Saikat Ghosh, Nicholas L Fletcher, Pie Huda, Zachary H Houston, Christopher B Howard, Maria E Lund, Yanling Lu, Douglas H Campbell, Bradley J Walsh, Kristofer J Thurecht
Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma. Molecular pharmaceutics (2023)
Saikat Ghosh, Pie Huda, Nicholas Fletcher, Douglas Campbell, Kristofer J Thurecht, Bradley J Walsh
Clinical development of an anti-GPC-1 antibody for the treatment of cancer. Expert opinion on biological therapy 22 (5) (2022)
Nicholas L Fletcher, A Prior, O Choy, James Humphries, Pie Huda, Saikat Ghosh, Zachary H Houston, Craig A Bell, Kristofer J Thurecht
Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance. Chemical communications (Cambridge, England) 58 (57) (2022)
Saikat Ghosh, Pie Huda, Nicholas L Fletcher, Christopher B Howard, Bradley Walsh, Douglas Campbell, Mark B Pinkham, Kristofer J Thurecht
Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Molecular pharmaceutics 19 (5) (2022)